HEADER ANTITUMOR PROTEIN 26-SEP-23 8WJY
TITLE PKMYT1_COCRYSTAL_CPD 4
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-
COMPND 3 INHIBITORY KINASE;
COMPND 4 CHAIN: A;
COMPND 5 SYNONYM: MYT1 KINASE;
COMPND 6 EC: 2.7.11.1;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PKMYT1, MYT1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA PHAGE ECSZW-2;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 2419741
KEYWDS INHIBITOR, CO-CRYSTAL, ANTITUMOR PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.WANG,C.WANG,T.LIU,H.QI,S.CHEN,X.CAI,M.ZHANG,A.ALIPER,F.REN,X.DING,
AUTHOR 2 A.ZHAVORONKOV
REVDAT 2 29-MAY-24 8WJY 1 JRNL
REVDAT 1 22-NOV-23 8WJY 0
JRNL AUTH Y.WANG,C.WANG,T.LIU,H.QI,S.CHEN,X.CAI,M.ZHANG,A.ALIPER,
JRNL AUTH 2 F.REN,X.DING,A.ZHAVORONKOV
JRNL TITL DISCOVERY OF TETRAHYDROPYRAZOLOPYRAZINE DERIVATIVES AS
JRNL TITL 2 POTENT AND SELECTIVE MYT1 INHIBITORS FOR THE TREATMENT OF
JRNL TITL 3 CANCER.
JRNL REF J.MED.CHEM. V. 67 420 2024
JRNL REFN ISSN 0022-2623
JRNL PMID 38146659
JRNL DOI 10.1021/ACS.JMEDCHEM.3C01476
REMARK 2
REMARK 2 RESOLUTION. 1.88 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.8.0267
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.96
REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 23376
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.174
REMARK 3 R VALUE (WORKING SET) : 0.172
REMARK 3 FREE R VALUE : 0.217
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900
REMARK 3 FREE R VALUE TEST SET COUNT : 1213
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.88
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1729
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94
REMARK 3 BIN R VALUE (WORKING SET) : 0.2540
REMARK 3 BIN FREE R VALUE SET COUNT : 85
REMARK 3 BIN FREE R VALUE : 0.3780
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2272
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 42
REMARK 3 SOLVENT ATOMS : 271
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.24
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 1.69000
REMARK 3 B22 (A**2) : 0.35000
REMARK 3 B33 (A**2) : -2.04000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): 0.148
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.139
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.101
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.515
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2411 ; 0.010 ; 0.013
REMARK 3 BOND LENGTHS OTHERS (A): 2277 ; 0.001 ; 0.015
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3266 ; 1.586 ; 1.667
REMARK 3 BOND ANGLES OTHERS (DEGREES): 5242 ; 1.356 ; 1.588
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 296 ; 8.754 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;26.435 ;20.977
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 396 ;13.065 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;19.400 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 277 ; 0.082 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2748 ; 0.012 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): 566 ; 0.001 ; 0.021
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1184 ; 2.568 ; 2.705
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1183 ; 2.567 ; 2.701
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1477 ; 3.903 ; 4.023
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1478 ; 3.902 ; 4.027
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1227 ; 3.142 ; 3.067
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1228 ; 3.141 ; 3.068
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1789 ; 4.835 ; 4.450
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2826 ; 7.535 ;32.358
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2767 ; 7.412 ;31.904
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.20
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 8WJY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 29-SEP-23.
REMARK 100 THE DEPOSITION ID IS D_1300041401.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 17-FEB-22
REMARK 200 TEMPERATURE (KELVIN) : 298
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : DIAMOND
REMARK 200 BEAMLINE : I03
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97626
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24659
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880
REMARK 200 RESOLUTION RANGE LOW (A) : 56.960
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 13.00
REMARK 200 R MERGE (I) : 0.16800
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 1.21300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 41.98
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: SM5-E1+30%GLY, VAPOR DIFFUSION,
REMARK 280 SITTING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.00500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.96000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.90500
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.96000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.00500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.90500
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 140 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 14710 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A -22
REMARK 465 HIS A -21
REMARK 465 HIS A -20
REMARK 465 HIS A -19
REMARK 465 HIS A -18
REMARK 465 HIS A -17
REMARK 465 HIS A -16
REMARK 465 SER A -15
REMARK 465 SER A -14
REMARK 465 GLY A -13
REMARK 465 GLN A -2
REMARK 465 SER A -1
REMARK 465 MET A 0
REMARK 465 HIS A 75
REMARK 465 GLY A 262
REMARK 465 ALA A 263
REMARK 465 GLY A 264
REMARK 465 GLU A 265
REMARK 465 VAL A 266
REMARK 465 PRO A 362
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 360 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 77 3.23 -65.67
REMARK 500 GLU A 87 -26.84 -146.43
REMARK 500 ALA A 88 -19.49 85.59
REMARK 500 VAL A 164 -74.69 -60.59
REMARK 500 ASP A 233 47.17 -145.23
REMARK 500 PRO A 243 -158.33 -5.92
REMARK 500 ASP A 251 76.07 60.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 GLY A 242 PRO A 243 -86.50
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY
REMARK 500
REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY
REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER
REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;
REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 500 I=INSERTION CODE).
REMARK 500
REMARK 500 M RES CSSEQI ANGLE
REMARK 500 GLY A 242 -11.05
REMARK 500
REMARK 500 REMARK: NULL
DBREF 8WJY A 75 362 UNP Q99640 PMYT1_HUMAN 75 362
SEQADV 8WJY MET A -22 UNP Q99640 INITIATING METHIONINE
SEQADV 8WJY HIS A -21 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY HIS A -20 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY HIS A -19 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY HIS A -18 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY HIS A -17 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY HIS A -16 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY SER A -15 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY SER A -14 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY GLY A -13 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY VAL A -12 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY ASP A -11 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY LEU A -10 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY GLY A -9 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY THR A -8 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY GLU A -7 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY ASN A -6 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY LEU A -5 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY TYR A -4 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY PHE A -3 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY GLN A -2 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY SER A -1 UNP Q99640 EXPRESSION TAG
SEQADV 8WJY MET A 0 UNP Q99640 EXPRESSION TAG
SEQRES 1 A 311 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU
SEQRES 2 A 311 GLY THR GLU ASN LEU TYR PHE GLN SER MET HIS GLN LEU
SEQRES 3 A 311 GLN PRO ARG ARG VAL SER PHE ARG GLY GLU ALA SER GLU
SEQRES 4 A 311 THR LEU GLN SER PRO GLY TYR ASP PRO SER ARG PRO GLU
SEQRES 5 A 311 SER PHE PHE GLN GLN SER PHE GLN ARG LEU SER ARG LEU
SEQRES 6 A 311 GLY HIS GLY SER TYR GLY GLU VAL PHE LYS VAL ARG SER
SEQRES 7 A 311 LYS GLU ASP GLY ARG LEU TYR ALA VAL LYS ARG SER MET
SEQRES 8 A 311 SER PRO PHE ARG GLY PRO LYS ASP ARG ALA ARG LYS LEU
SEQRES 9 A 311 ALA GLU VAL GLY SER HIS GLU LYS VAL GLY GLN HIS PRO
SEQRES 10 A 311 CYS CYS VAL ARG LEU GLU GLN ALA TRP GLU GLU GLY GLY
SEQRES 11 A 311 ILE LEU TYR LEU GLN THR GLU LEU CYS GLY PRO SER LEU
SEQRES 12 A 311 GLN GLN HIS CYS GLU ALA TRP GLY ALA SER LEU PRO GLU
SEQRES 13 A 311 ALA GLN VAL TRP GLY TYR LEU ARG ASP THR LEU LEU ALA
SEQRES 14 A 311 LEU ALA HIS LEU HIS SER GLN GLY LEU VAL HIS LEU ASP
SEQRES 15 A 311 VAL LYS PRO ALA ASN ILE PHE LEU GLY PRO ARG GLY ARG
SEQRES 16 A 311 CYS LYS LEU GLY ASP PHE GLY LEU LEU VAL GLU LEU GLY
SEQRES 17 A 311 THR ALA GLY ALA GLY GLU VAL GLN GLU GLY ASP PRO ARG
SEQRES 18 A 311 TYR MET ALA PRO GLU LEU LEU GLN GLY SER TYR GLY THR
SEQRES 19 A 311 ALA ALA ASP VAL PHE SER LEU GLY LEU THR ILE LEU GLU
SEQRES 20 A 311 VAL ALA CYS ASN MET GLU LEU PRO HIS GLY GLY GLU GLY
SEQRES 21 A 311 TRP GLN GLN LEU ARG GLN GLY TYR LEU PRO PRO GLU PHE
SEQRES 22 A 311 THR ALA GLY LEU SER SER GLU LEU ARG SER VAL LEU VAL
SEQRES 23 A 311 MET MET LEU GLU PRO ASP PRO LYS LEU ARG ALA THR ALA
SEQRES 24 A 311 GLU ALA LEU LEU ALA LEU PRO VAL LEU ARG GLN PRO
HET W9X A 401 32
HET DMS A 402 4
HET GOL A 403 6
HETNAM W9X [6-AZANYL-5-(2,6-DIMETHYL-3-OXIDANYL-PHENYL)-2,3-
HETNAM 2 W9X DIMETHYL-PYRROLO[2,3-B]PYRAZIN-7-YL]-(6,7-DIHYDRO-
HETNAM 3 W9X 4~{H}-PYRAZOLO[1,5-A]PYRAZIN-5-YL)METHANONE
HETNAM DMS DIMETHYL SULFOXIDE
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 W9X C23 H25 N7 O2
FORMUL 3 DMS C2 H6 O S
FORMUL 4 GOL C3 H8 O3
FORMUL 5 HOH *271(H2 O)
HELIX 1 AA1 SER A 104 SER A 109 1 6
HELIX 2 AA2 GLY A 147 GLY A 165 1 19
HELIX 3 AA3 SER A 193 GLY A 202 1 10
HELIX 4 AA4 PRO A 206 GLN A 227 1 22
HELIX 5 AA5 LYS A 235 ALA A 237 5 3
HELIX 6 AA6 ASP A 251 LEU A 255 5 5
HELIX 7 AA7 ASP A 270 MET A 274 5 5
HELIX 8 AA8 ALA A 275 GLY A 281 5 7
HELIX 9 AA9 THR A 285 ASN A 302 1 18
HELIX 10 AB1 GLY A 308 LEU A 315 1 8
HELIX 11 AB2 PRO A 321 ALA A 326 1 6
HELIX 12 AB3 SER A 329 GLU A 341 1 13
HELIX 13 AB4 THR A 349 ALA A 355 1 7
HELIX 14 AB5 LEU A 356 ARG A 360 5 5
SHEET 1 AA1 6 ARG A 80 ARG A 81 0
SHEET 2 AA1 6 LEU A 173 GLU A 179 -1 O GLU A 178 N ARG A 80
SHEET 3 AA1 6 ILE A 182 GLU A 188 -1 O TYR A 184 N TRP A 177
SHEET 4 AA1 6 LEU A 135 SER A 141 -1 N ALA A 137 O THR A 187
SHEET 5 AA1 6 GLY A 122 SER A 129 -1 N GLU A 123 O ARG A 140
SHEET 6 AA1 6 PHE A 110 GLY A 119 -1 N LEU A 113 O LYS A 126
SHEET 1 AA2 2 LEU A 229 VAL A 230 0
SHEET 2 AA2 2 VAL A 256 GLU A 257 -1 O VAL A 256 N VAL A 230
SHEET 1 AA3 2 ILE A 239 LEU A 241 0
SHEET 2 AA3 2 CYS A 247 LEU A 249 -1 O LYS A 248 N PHE A 240
CRYST1 46.010 55.810 113.920 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021734 0.000000 0.000000 0.00000
SCALE2 0.000000 0.017918 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008778 0.00000